000 04032nam a22005175i 4500
001 vtls000562382
003 RU-ToGU
005 20210922090910.0
007 cr nn 008mamaa
008 170213s2015 it | s |||| 0|eng d
020 _a9788847057111
_9978-88-470-5711-1
024 7 _a10.1007/978-88-470-5711-1
_2doi
035 _ato000562382
040 _aSpringer
_cSpringer
_dRU-ToGU
050 4 _aRD651-678
072 7 _aMNK
_2bicssc
072 7 _aMED085000
_2bisacsh
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
245 1 0 _aTreatment of Peritoneal Surface Malignancies
_helectronic resource
_bState of the Art and Perspectives /
_cedited by Angelo Di Giorgio, Enrico Pinto.
260 _aMilano :
_bSpringer Milan :
_bImprint: Springer,
_c2015.
300 _aXVI, 396 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aUpdates in Surgery,
_x2280-9848
505 0 _aForeword -- Preface 1 -- Preface 2 -- Introduction -- Part 1 Background -- 1 Peritoneal surface malignancies: definition -- 2 Epidemiology: the extent of the problem -- 3: Intraperitoneal spread: origin and mechanisms -- 4 Pathology and patterns of molecular biology -- 5 Classification of intraperitoneal spread -- 6 Diagnosis and assessment: clinical, radiological, and laparoscopic -- Part 2 Treatment -- 7 Rationale for integrated procedures (combined cytoreduction and HIPEC) -- 8 Peritonectomy techniques -- 9 HIPEC techniques -- 10 The role of surgery -- 11 The role of systemic chemotherapy -- 12 Anesthesiology and perioperative management -- 13 Patient selection for treatment -- 14 Morbidity and mortality -- 15 Organizational problems, costs, and data collection -- Part 3 Results of integrated treatment -- 16 Pseudomyxoma peritonei -- 17 Peritoneal mesothelioma -- 18  Peritoneal carcinomatosis from gastric cancer -- 19  Peritoneal carcinomatosis from colorectal cancer -- 20  Peritoneal carcinomatosis from ovarian and gynecological cancers -- 21 Other primary peritoneal surface malignancies -- 22  Peritoneal carcinomatosis from other primary tumors -- 23 Palliative treatments -- Part 4 Perspectives -- 24 New trials -- 25 Main topics of discussion and new trends -- Part 5 Conclusions.
520 _aThis monograph summarizes state of the art knowledge regarding peritoneal surface malignancies, with in-depth description of treatment options and the results achieved to date. It explores the most challenging problems on the basis of the authors’ very extensive clinical experience and examines the most relevant clinical trials. A comprehensive summary is provided of all phase 2 studies (the only available completed studies) and of ongoing and future phase 3 studies. Particular attention is paid to the results of integrated treatment comprising cytoreduction (peritonectomy) and hyperthermic intraperitoneal chemotherapy (HIPEC). Helpful background information is also included on the definition and clinical assessment of each clinical form. The book, drawing on data from the entire Italian experience as well as world literature, will be an outstanding benchmark for health professionals and researchers.
650 0 _amedicine.
_9566220
650 0 _aAbdominal Surgery.
_9307640
650 0 _aSurgical Oncology.
_9303089
650 0 _aPharmacotherapy.
_9428996
650 1 4 _aMedicine & Public Health.
_9566221
650 2 4 _aSurgical Oncology.
_9303089
650 2 4 _aAbdominal Surgery.
_9307640
650 2 4 _aPharmacotherapy.
_9428996
700 1 _aGiorgio, Angelo Di.
_eeditor.
_9471073
700 1 _aPinto, Enrico.
_eeditor.
_9471074
710 2 _aSpringerLink (Online service)
_9143950
773 0 _tSpringer eBooks
830 0 _aUpdates in Surgery,
_9454190
856 4 0 _uhttp://dx.doi.org/10.1007/978-88-470-5711-1
912 _aZDB-2-SME
999 _c417430